Cabot Undervalued Stocks Advisor Special Bulletin
Two portfolio stocks delivered strong earnings beats are their recommendations are raised to Strong Buy. A third stock delivered a strong earnings beat.
Read More
investment market
Read More
investment market Archives
Cabot Undervalued Stocks Advisor Special Bulletin
One portfolio stock is up on news of a successful drug trial and another reported a strong earnings beat.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
When market pundits toss about terms like “growth stocks” and “value stocks,” it seems as if they’re saying “companies that are growing” vs. “companies that are not growing,” so we sugar-coat these companies and pretend that they have ‘value.” That’s not really what vs...
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
Baker Hughes changes their corporate name and stock symbol. And, two stocks report third-quarter earnings beats.
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
Two stocks report earnings and two more are rising again.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
There’s been a variety of news pertaining to airlines, and also to the Boeing 737 MAX jet problem, in recent weeks. It can be hard to know which industry-specific stocks to own and which to ignore. I always use profit growth as my line...
Read More
Cabot Undervalued Stocks Advisor Weekly Update
The markets have been quiet, heading into earnings season, which begins next week with financial stocks and a couple of our stocks move to Buy recommendations today after recent pullbacks.
Read More
Cabot Marijuana Investor 919
Lots of Crosscurrents!
The good news is that yesterday the U.S. House of Representatives voted in favor of the SAFE Banking Act (the acronym stands for "Secure and Fair Enforcement"), which would shield banks and other financial institutions from being held liable for serving businesses...
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
Yesterday, investment manager Elliott Management Corp. sent a letter to Marathon Petroleum (MPC), the nation’s largest energy refiner, seeking changes that could potentially increase the MPC share price.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
The S&P 500 index continues to act well, rising to new highs in July, conducting a very orderly pullback in August, and rebounding in September. To my eyes, the price chart still looks strong.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
Oil prices are volatile now that about half of Saudi Arabia’s oil production is temporarily curtailed. Rising oil prices can help oil and chemical stocks, and hurt airline stocks.
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
Oil prices and shares of oil-related stocks surged this morning after a terrorist attack on Saudi Arabian oil fields shut down about half of Saudi Arabia’s daily oil output.
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
One of our portfolio stocks moves is being retired and there is news on five more.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
The S&P 500 (SPX) stock index rose to new all-time highs in July, commenced a pullback during the final week of that month, then traded between 2840-2940 in a very orderly pattern during August. For that, I am grateful.
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
One of our portfolio stocks moves from Strong Buy to Hold.
Read More
Cabot Marijuana Investor 819
Buying Opportunity
It’s been rather frustrating to see cannabis stocks falling day after day, week after week, while the companies’ quarterly reports (with the exception of Canopy Growth) continue to reveal that business is booming. But that’s how the market works.
First, cannabis stocks attracted slew...
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
Three retail stocks reported earnings.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
This week’s update of Cabot Undervalued Stocks Advisor is focused on portfolio stocks that are being affected by recent news or upcoming earnings reports. Next week’s September issue will include all portfolio stocks, with at least one new portfolio addition.
Read More
Cabot Undervalued Stocks Advisor Special Bulletin
A Spanish news outlet, Intereconomia.com, is reporting that biotech company Amgen (AMGN) is in talks to buy Alexion Pharmaceuticals (ALXN) for close to $200 per share.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
Today’s and next week’s issues of Cabot Undervalued Stocks Advisor are going to look a bit different. I won’t be reviewing all of our portfolio stocks today. Many Wall Street analysts are on vacation, so there will be very little in the way changes...
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up